(Q40652990)

22 September 2017

Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy (English)

1 reference

22 September 2017

S Baum

1

1 reference

22 September 2017

A Ashok

2

1 reference

22 September 2017

G Gee

3

1 reference

22 September 2017

S Dimitrova

4

1 reference

22 September 2017

W Querbes

5

1 reference

22 September 2017

J Jordan

6

1 reference

22 September 2017

Walter J Atwood

7

1 reference

22 September 2017

1 January 2003

1 reference

22 September 2017

Journal of NeuroVirology

1 reference

22 September 2017

9 Suppl 1

1 reference

22 September 2017

32-37

1 reference

https://scigraph.springernature.com/pub.10.1080/13550280390195342

22 September 2017

0 references

cites work

JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

1 reference

12 December 2020

A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients

1 reference

12 December 2020

Atypical antipsychotics: mechanism of action.

1 reference

12 December 2020

JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy

1 reference

12 December 2020

A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy

1 reference

12 December 2020

Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML).

1 reference

12 December 2020

A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.

1 reference

12 December 2020

JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis.

1 reference

12 December 2020

Extrapyramidal symptoms with ritonavir/indinavir plus risperidone

1 reference

12 December 2020

Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells.

1 reference

12 December 2020

Neuronal damage of the substantia nigra in HIV-1 infected brains

1 reference

12 December 2020

The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line

1 reference

12 December 2020

Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids

1 reference

12 December 2020

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

1 reference

12 December 2020

Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region

1 reference

12 December 2020

Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.

1 reference

12 December 2020

Dopamine systems in human immunodeficiency virus-associated dementia.

1 reference

12 December 2020

Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

1 reference

12 December 2020

Establishment of a line of human fetal glial cells that supports JC virus multiplication

1 reference

12 December 2020

Incidence of extrapyramidal syndromes in AIDS patients and a comparison group of medically ill inpatients.

1 reference

12 December 2020

10.1080/13550280390195342

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference